Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Topas Advanced Polymers is the world's leading manufacturer of Cyclic Olefin Copolymers (COC), a high-purity class of amorphous polymers used extensively in the healthcare and life sciences sectors. The company's materials are critical for the production of high-performance medical devices, including pre-filled syringes, vials, and wearable drug delivery systems, where they serve as a high-quality alternative to glass. Their COC resins are characterized by exceptional optical clarity, low leachables and extractables, and superior moisture barrier properties. Beyond pharmaceutical packaging, Topas provides essential materials for microfluidics and point-of-care diagnostic disposables. Headquartered in Germany with significant operations in the United States, the company serves a global clientele of pharmaceutical and medical technology firms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Topas Advanced Polymers.